Brief: Biomerieux Submits Dual 510K And Clia-Waiver Application To FDA For Biofire Spotfire Panel
Sept 22 (Reuters) - Biomerieux SA BIOX.PA :
* SUBMITS DUAL 510(K) AND CLIA-WAIVER APPLICATION TO FDA FOR
BIOFIRE SPOTFIRE RESPIRATORY/SORE THROAT (R/ST) PANEL
Source text for Eikon: ID:nNDL9S9CZg
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biomerieux SA
See all newsFactbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development